LY4298445
/ Eli Lilly
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
March 24, 2026
A Study of LY4298445 in Healthy Participants and Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)
(clinicaltrials.gov)
- P1 | N=63 | Recruiting | Sponsor: Eli Lilly and Company | Not yet recruiting ➔ Recruiting
Enrollment open • Immunology • Inflammatory Arthritis • Lupus • Rheumatoid Arthritis • Rheumatology • Systemic Lupus Erythematosus • CRP
December 12, 2025
A Study of LY4298445 in Healthy Participants and Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)
(clinicaltrials.gov)
- P1 | N=63 | Not yet recruiting | Sponsor: Eli Lilly and Company
New P1 trial • Immunology • Inflammatory Arthritis • Lupus • Rheumatoid Arthritis • Rheumatology • Systemic Lupus Erythematosus
1 to 2
Of
2
Go to page
1